Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue
Submit an article Journal homepage
92
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Cheong-Ju Kim1 Department of Internal Medicine, National Health Insurance System Ilsan Hospital, Koyang
,
Hyoung-Kyu Yoon2 Division of Pulmonology, Department of Internal Medicine, St Mary’s Hospital, College of Medicine, The Catholic University of Korea
,
Myung-Jae Park3 Division of Respiratory and Critical Care Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul
,
Kwang-Ha Yoo4 Department of Internal Medicine, Konkuk University School of Medicine, Gwangjin-gu
,
Ki-Suck Jung5 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical School, Anyang-si
,
Jeong-Woong Park6 Division of Pulmonary and Allergy Medicine, Gachon University Gil Medical Center, Incheon
,
Seong Yong Lim7 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine
,
Jae Jeong Shim8 Department of Internal Medicine, Korea University College of Medicine, Seoul
,
Yong Chul Lee9 Department of Internal Medicine and Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonbuk
,
Young-Sam Kim10 Department of Internal Medicine, Yonsei University College of Medicine
,
Yeon-Mok Oh11 Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine
,
Song Kim12 Clinical Development and Medical Affairs, Novartis Korea Ltd., Seoul
&
Chul-Gyu Yoo13 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 1589-1596 | Published online: 29 May 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Ho Cheol Kim, Tae Hoon Kim, Chin Kook Rhee, Minkyu Han & Yeon-Mok Oh. (2019) Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation. Therapeutics and Clinical Risk Management 15, pages 377-387.
Read now
Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Kyung Ho Kang, Chin Kook Rhee, Seoung Ju Park & Jae Jeong Shim. (2018) Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3381-3387.
Read now

Articles from other publishers (11)

Sankalp Yadav & Gautam Rawal. (2023) Destroyed lung syndrome. IP Indian Journal of Immunology and Respiratory Medicine 8:1, pages 4-5.
Crossref
Sankalp Yadav. (2023) Destroyed Lung Syndrome in a Young Indian Male: A Case Report. Cureus.
Crossref
Vinita Awasthi, Sarvesh Singh, Narendra Kumar, Manoj Kumar, AmodKumar Sachan, Rajiv Garg & Rahul Kumar. (2023) Evaluation of medical adherence, adverse drug reactions, and quality of life in post tubercular obstructive airway disease. Perspectives in Clinical Research 14:1, pages 20.
Crossref
S. Singh, B.W. Allwood, T.L. Chiyaka, L. Kleyhans, C.C. Naidoo, S. Moodley, G. Theron & L.N. Segal. (2022) Immunologic and imaging signatures in post tuberculosis lung disease. Tuberculosis 136, pages 102244.
Crossref
Hongyun Ruan, Fangchao Liu, Ming Han & Changfan Gong. (2021) Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung. BMC Pulmonary Medicine 21:1.
Crossref
Bumhee Yang, Hayoung Choi, Sun Hye Shin, Youlim Kim, Ji-Yong Moon, Hye Yun Park & Hyun Lee. (2021) Association of Ventilatory Disorders with Respiratory Symptoms, Physical Activity, and Quality of Life in Subjects with Prior Tuberculosis: A National Database Study in Korea. Journal of Personalized Medicine 11:7, pages 678.
Crossref
Brian W. Allwood, Anthony Byrne, Jamilah Meghji, Andrea Rachow, Marieke M. van der Zalm & Otto Dagobert Schoch. (2021) Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration 100:8, pages 751-763.
Crossref
Ho Cheol Kim, Tae Hoon Kim, Ye-Jee Kim, Chin Kook Rhee & Yeon-Mok Oh. (2019) Effect of tiotropium inhaler use on mortality in patients with tuberculous destroyed lung: based on linkage between hospital and nationwide health insurance claims data in South Korea. Respiratory Research 20:1.
Crossref
Chin Kook Rhee, Ngo Quy Chau, Faisal Yunus, Kazuto Matsunaga & Diahn‐Warng Perng. (2019) Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology. Respirology 24:10, pages 1018-1025.
Crossref
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Tae Hoon Kim, Chin Kook RheeYeon-Mok Oh. (2019) Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation. Tuberculosis and Respiratory Diseases 82:1, pages 35.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.